학술논문

Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma
Document Type
Article
Source
In: Leukemia and Lymphoma. (Leukemia and Lymphoma, March 2012, 53(3):411-416)
Subject
Language
English
ISSN
10428194
10292403